Status
Conditions
Treatments
About
The goal of this study is to learn if sending text message invitations increases participation in colorectal cancer screening among 45-49 year olds in Yingge District, New Taipei City. It will also assess the effectiveness of this method. The main questions it aims to answer are:
•Does sending text message invitations increase the number of residents who complete fecal occult blood test (FOBT)? This study will compare a group receiving text message invitations to a control group receiving standard notifications to see if text messages are an effective way to increase screening rates.
Participants will:
Full description
This study is a randomized controlled trial designed to evaluate the effectiveness of active SMS (Short Message Service) invitations for increasing participation in colorectal cancer screening among residents aged 45-49 in Yingge District, New Taipei City.
Background: Colorectal cancer is a significant public health concern, and early detection through screening is crucial for improving outcomes. This study aims to explore a simple and cost-effective method to increase screening rates in a specific population group (45-49 years old) where screening just initiated.
Objectives: The primary objective is to assess whether sending active SMS invitations increases the rate of fecal occult blood test (FOBT) completion among the target population.
Study Design: The study employs parallel randomized controlled trial design.
Eligible participants will be randomly assigned to one of two groups:
Intervention:
The contents of SMS is "大腸癌年輕化!國家新政策,符合45-49歲,歡迎參加公費糞便潛血篩檢,顧健康自己來。即日起至8/31止,週一~五8:30-11:30至本所可領採檢管或諮詢電話:098176819鶯歌衛生所關心您。 In English: "Colorectal cancer is affecting younger people! Under a new national policy, those aged 45-49 are welcome to participate in government-funded fecal occult blood screening to take charge of their own health. From now until August 31st, Monday to Friday between 8:30 AM and 11:30 AM, you can visit our office to pick up a collection tube. For inquiries, please call: 0981-768-19 - Yingge Health Center cares about you."
Recruitment: Participants will be identified through the health department's information system, which contains records of residents eligible for the national colorectal cancer screening program and their mobile phone numbers. There is no separate recruitment or enrollment procedure.
•Sample Size: A total of 6,708 eligible residents will be randomly assigned to the intervention and control groups. The sample size is calculated based on previous research, which indicates that approximately 13.1% of individuals in this age group participate in FOBT screening without active intervention. The study aims to increase participation by 5%, reaching an 18% participation rate with SMS invitations.
Timeline: The study will be conducted over from August 5, 2025 to Sep 18, 2025.
Data Collection and Management:
Outcome Measures:
•Primary Endpoint: Numbers of completed fecal occult blood test. Data Analysis: The primary analysis will be conducted using an intention-to-treat (ITT) approach, where all participants will be included in the analysis based on their assigned group, regardless of whether they received the intervention or completed the screening.
Ethical Considerations: The study has been designed to protect the privacy and confidentiality of participants. Data will be de-identified and stored securely. All personal data will be protected through anonymized coding and data encryption. SMS dissemination will be handled by a third-party vendor under confidentiality agreements, and no personally identifiable information will be shared beyond phone number use for message delivery. The project is funded through existing administrative cancer screening budgets, without external sponsorship. The study will comply with all relevant ethical guidelines and regulations.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
6,708 participants in 2 patient groups
Loading...
Central trial contact
Sherry Yueh-Hsia Chiu, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal